Table 2: Follow up after rituximab therapy.

Patient number RTX total dose per course (mg) CD19 count after RTX (%) Growth velocity (cm/year) eGFR (ml/min/1.73 m2) Albumin (g/dL) Number of relapses Time to first relapse (days)
0 12m 0 12m 0 12m -12m 12m
1 1000 0 2.5 3.0 100 106 45 / 4 0 426
2 2000 0.3 0.0 0.0 124 132 38 42 4 1 213
3 1000 0.1 0.0 0.0 84 89 27 34 1 1 234
4 1000 0 0.0 0.0 46 59 33 20 4 2 266
5 1000 0 2.9 1.3 94 105 39 43 3 0 531
6 1000 0 3.0 3.7 155 133 25 28 5 1 322
7 1000 0.2 3.0 4.3 108 112 24 44 7 3 158
8 1000 0.2 5.6 12.4 97 124 42 33 2 1 349
9 1000 0.2 2.0 2.7 118 95 30 45 2 0 377
10 1000 0.2 4.1 4.9 97 112 39 38 2 0 409
11 1000 0.3 2.2 4.8 92 87 26 44 5 0 574

RTX = Rituximab; -12m = 1 year before rituximab therapy; 0 = At time of rituximab therapy; 12m = 1 year after rituximab therapy.